CSIMarket
 
Blueprint Medicines Corporation  (BPMC)
Other Ticker:  
 
 

Blueprint Medicines Cash flow Statement Quarterly

BPMC



Select the Financial Report:   Period:   Fiscal Year:



Cash flow Statement
(Quarterly, GAAP in millions $)

(Dec 31 2023)
12 Months
(Sep 30 2023)
9 Months
(Jun 30 2023)
6 Months
(Mar 31 2023)
3 Months
(Dec 31 2022)
12 Months
Income -506.98 -396.07 -262.35 -129.56 -557.52
Depreciation & amortization 11.67 10.13 7.26 3.68 11.74
Amortization of Other Assets - - - - -
Increase (Decrease) in Deferred Revenue - - - - -
Restructuring & Impairment Charges - - - - -
Provision for Loan, Lease, and Other Losses - - - - -
Increase (Decrease) in Inventories -4.37 -5.20 -8.11 0.08 -8.92
R & D, Environmental and Other Expense - - - - -
Gain (Loss) on Disposition of Assets - - - - -
Share-based Compensation 92.67 70.09 47.02 23.20 98.97
Income (Loss) from Equity Method Investments - - - - -
Fair Value Adjustment of Warrants - - - - -
Increase Decrease In Contract With Customer Liability -10.28 -9.96 -11.10 -19.95 -14.44
Accretion Of Premiums And Discounts On Investments - - - - -
Lease Right Of Use Asset Amortization 6.76 4.46 2.20 6.21 9.59
Noncash Interest Expense 11.89 8.30 4.64 8.39 -
Increase Decrease In Customer Assets 13.02 10.29 9.90 9.28 -
Income taxes 1.15 2.34 -3.61 -0.70 2.62
Losses/ -gains on Investments net - - - - -
Increase (Decrease) in Accounts Receivable -20.72 -18.97 -13.11 -4.95 1.57
Increase (Decrease) in Accounts Payable 1.88 4.24 4.22 7.81 -5.82
Increase (Decrease) in Accrued Liabilities 1.08 -15.10 -25.69 -23.69 9.37
Deferred Revenue and Customer Advances and Deposits - - - - -
Increase (Decrease) in Prepaid Expense and Other Assets 3.21 -2.45 1.68 5.74 -16.94
Other Working Capital -11.95 -8.96 -8.66 -7.66 -16.32
Other Noncash Items - - - - -
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities -28.10 -19.37 -5.16 -2.56 -35.60
Discontinued operations - - - - -
Net Cash flow from Operating Activities -436.85 -357.92 -253.44 -122.96 -502.28
Capital Expenditures -16.06 -11.39 -5.14 -2.58 -8.92
Sale of Capital Items - - - - -
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities 1,056.47 855.37 617.77 308.25 349.37
Payments to Acquire Available-for-sale Securities, Debt -766.36 -648.71 -407.77 -132.88 -489.71
Real Estate Investments - - - - -
Increase (Decrease) in Restricted Cash - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments for (Proceeds from) Other Investments - - - - -
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Acquisition Net of Cash Acquired - - - - -
Interest in Subsidiaries and Affiliates - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - -0.29
Other Net 0.00 0.00 - - -
Discontinued operations - - - - -
Net Cash flow from Investing Activities 274.04 195.27 204.86 172.79 -149.54
Short-term debt Net - - - - -
Other borrowing transactions - - - - -
Long-term debt - borrowings - - - - -
Long-term debt - repayments 97.93 97.97 - - 553.61
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock - - - - -
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net -125.50 -126.83 -127.51 -124.90 -215.44
Payment Of Offering Costs - - - - -
Net Proceeds From Stock Option Exercises And Employee Stock Purchase Plan 5.73 5.30 - 5.69 3.76
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 124.90 124.90 124.90 215.12 215.12
Capital Expenditures Incurred But Not Yet Paid 1.92 2.60 - 0.20 1.83
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities 119.23 103.70 5.30 - 561.81
Effect of exchange rate on cash flow 0.20 -0.29 0.26 0.20 -0.21
Discontinued operations - - - - -
Free Cash Flow -452.91 -369.31 -258.57 -125.55 -511.20
Total Cash Flow -43.58 -58.95 -43.28 49.83 -90.01
Cash & cash equiv. at beg. of the Year - - - - -
Cash & cash equivalents at end of period - - - - -
Cash Interests paid - - - - -
Cash Income taxes paid -0.05 0.76 0.68 0.31 6.51




Untitled Document





	
	


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com